By: JanOne Team - - November 15, 2019
As society continues working on solutions to reduce the number of opioid addiction cases and overdoses, many people wonder what is on the horizon for 2020. Federal and state governments continue to ramp up efforts to fight the opioid crisis, and yet despite new programs and summits being proposed, the National Institute on Drug Abuse (NIDA) has reported some significant cuts to the funding for research and grants to unveil new approaches and effective solutions.
The NIDA reports that President Trump’s new budget for 2020 includes cuts in funding to all aspects of its research regarding drug addiction, which includes the opioid crisis. Relative to 2019 funds, there will be a $7 million cut to research management and support. A $9.6 million reduction to funding will impact intramural research alone, and research centers will lose $5.9 million in funding. The most significant cuts are to other research, which will lose $43.2 million in 2020, and to research project grants, which will lose $56 million. Overall, the cuts in drug abuse research funding proposed by the president total a decrease of $123.5 million.
The NIDA’s priorities for 2020 include an emphasis on projects that can potentially address addiction and misuse of opioids. It aims to improve addiction treatment and prevention through evidence-based findings, to develop new and less addictive medications and to advance basic science. This multipronged effort involves several different strategies:
It appears that the NIDA will be putting more effort into understanding the mechanisms of opioid addiction and producing effective research results. Much of its language also includes directing funding to better implementing research results into actual solutions.
Several events are on the horizon in 2020 that aim to disseminate more information and provide a platform for collaboration. The U.S. Department of Agriculture is hosting the 2020 Rx Drug Abuse Heroin & Drug Summit, the largest national collaboration of professionals from local, state, and federal agencies, business, academia, treatment providers, and allied communities impacted by substance use disorder. The summit will be held April 13-16 in Nashville, Tennessee.
The American College of Medical Technology is also hosting a seminar—the 2020 Symposium: Opioid Epidemic: Controversies and Creative Solutions. This promising event will have discussions regarding more controversial topics such as urban greening, mobile buprenorphine induction and safe-injection sites. The symposium will also outline big-picture approaches on how to tackle the opioid epidemic. This one-day event will be held at the Grand Hyatt in New York City on March 12.
September 19, 2019
JanOne sees every day as an opportunity for fresh ideas to end the opioid epidemic, the worst drug crisis in our nation’s history.
As a NASDAQ-listed company, JanOne draws private-sector resources into this urgent fight. We seek innovative treatments—focusing on developing revolutionary, non-addictive drugs that kill pain, not people.
January 16, 2020
January 15, 2020
January 7, 2020
🚨JanOne is one step closer to finding a solution to non-addictive pain relief with the appointment of Dr. Christopher Kevil, Ph.D., to its scientific advisory board.
#JanOneSolution #KillPainNotPeople https://janone.com/leading-cardiovascular-researcher-and-pad-treatment-pioneer-dr-christopher-kevil-to-chair-janone-scientific-advisory-board/
💊Roughly 21 to 29% of patients prescribed #Opioids for chronic pain misuse them;
💊Between 8 and 12% develop an opioid use disorder;
➡️Learn more information on how #JanOne is working solutions to the opioid crisis: https://soo.nr/q6xn
Did you know?
• #Opioid painkillers such as oxycodone, hydrocodone & codeine have a stronger effect on women than on men?
• Women are more likely to develop an opioid addiction, and they also have a higher risk of relapse. #WomensHealth #JanOne